"AI-based technology is slowly becoming interwoven within the everyday life and workflow of oncologists today." The revolution of AI within oncology is here. LungOI is the first AI-based Rapid Biomarker Profiling Laboratory Developed Test to identify actionable alterations in NSCLC patients. LungOI is a multi-gene biomarker test clinically available through our CLIA Certified Lab, providing test results in one day. DM us for more information on LungOI! #NSCLC #BiomarkerTesting #LungCancer #PrecisionMedicine #AIinHealthcare
"AI-based technology is slowly becoming interwoven within the everyday life and workflow of oncologists today." The revolution of AI within oncology is here. In a new editorial for ASCO Daily News, Dr. Matthew Kurian and Dr. Douglas Flora discuss how AI is already used in many diagnostic tools and stress the need to better understand these technologies in order to bring AI into everyday practice: https://lnkd.in/evhz4dvW